Login

DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Navigating the Future of Energy: Rhett Bennett on Black Mountain's Expansion and the Critical Role of Nickel | Rhett Bennett, CEO, Black Mountain Energy Ltd.
00:10:00
Shreevar Kheruka on Borosil's Participation in Mumbai Trade Show and Market Growth | Shreevar Kheruka, CEO, Borosil Ltd.
00:10:00
Paul West-Sells on Western Copper and Gold's Casino Project Development in Yukon
00:10:00
Banana Capital Invests in companies with category-defining products with differentiated distribution channels|Turner Novak,Founder and Investor,Banana Capital
00:10:00
Champion Iron Eyes Expansion in High-Grade Iron Ore for Decarbonizing Steel Industry | David Cataford, CEO , Champion Iron Ltd.
00:10:00
venture capital firm and the premiere investor in developer first startups|Joe Ruscio,General Partner,Heavybit
00:10:00
Transparency and Visibility: The Power of AP Automation | Annie Hackman Schrenk , Director Sales & Marketing AT Top Image System
00:10:00
The leading Private Equity Firm exclusively focused in Musculoskeletal Healthcare|Mike Mogul,Managing Partner,HealthpointCapital LLC
00:10:00
Exploring IRAs with Klaas Financial CEO Maleeah Cuevas and CFP Kyle Kite| Maleeah Cuevas, CEO, Klaas Financial.
00:10:00
Fission Uranium: Pioneering Low-Cost Uranium Production with the High-Grade PLS Project
00:10:00
Gordon Haskett analyst John Inch, holding a neutral rating on GE with a $7 price target, expresses skepticism despite the company's cash flow beat.
00:10:00
Mr. Anandan M Discusses the Importance of Risk and Reward in Business Strategy | Mr. Anandan M , Chairman, Aptus Value Housing Finance India Ltd.

© 2026 Nehu